Press Release: Rexahn : REXAHN PARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Rexahn Pharmaceuticals, Inc. - REXN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of...
Read full article »
Rexahn is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Read more